GO:0005654 | nucleoplasm | 3.19e-05 | 3.12e-01 | 3.216 | 5 | 55 | 876 |
GO:0003678 | DNA helicase activity | 4.79e-05 | 4.68e-01 | 7.499 | 2 | 3 | 18 |
GO:0006271 | DNA strand elongation involved in DNA replication | 1.27e-04 | 1.00e+00 | 6.810 | 2 | 8 | 29 |
GO:0006281 | DNA repair | 1.69e-04 | 1.00e+00 | 4.588 | 3 | 19 | 203 |
GO:0032508 | DNA duplex unwinding | 2.19e-04 | 1.00e+00 | 6.421 | 2 | 5 | 38 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 2.43e-04 | 1.00e+00 | 6.347 | 2 | 6 | 40 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 3.65e-04 | 1.00e+00 | 6.054 | 2 | 3 | 49 |
GO:0006289 | nucleotide-excision repair | 4.28e-04 | 1.00e+00 | 5.941 | 2 | 9 | 53 |
GO:0004151 | dihydroorotase activity | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0004070 | aspartate carbamoyltransferase activity | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0004088 | carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0070335 | aspartate binding | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0070409 | carbamoyl phosphate biosynthetic process | 6.14e-04 | 1.00e+00 | 10.668 | 1 | 1 | 1 |
GO:0016363 | nuclear matrix | 8.11e-04 | 1.00e+00 | 5.479 | 2 | 7 | 73 |
GO:0042802 | identical protein binding | 8.71e-04 | 1.00e+00 | 3.786 | 3 | 7 | 354 |
GO:0005524 | ATP binding | 8.93e-04 | 1.00e+00 | 2.868 | 4 | 23 | 892 |
GO:0005634 | nucleus | 1.34e-03 | 1.00e+00 | 1.589 | 6 | 67 | 3246 |
GO:0003910 | DNA ligase (ATP) activity | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0003909 | DNA ligase activity | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0071733 | transcriptional activation by promoter-enhancer looping | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0043141 | ATP-dependent 5'-3' DNA helicase activity | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0006543 | glutamine catabolic process | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0044205 | 'de novo' UMP biosynthetic process | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0071899 | negative regulation of estrogen receptor binding | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:0051414 | response to cortisol | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0071169 | establishment of protein localization to chromatin | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0006228 | UTP biosynthetic process | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 1 | 4 |
GO:0006273 | lagging strand elongation | 2.46e-03 | 1.00e+00 | 8.668 | 1 | 2 | 4 |
GO:0000398 | mRNA splicing, via spliceosome | 2.47e-03 | 1.00e+00 | 4.668 | 2 | 8 | 128 |
GO:0016020 | membrane | 2.83e-03 | 1.00e+00 | 2.431 | 4 | 38 | 1207 |
GO:0005730 | nucleolus | 2.92e-03 | 1.00e+00 | 2.419 | 4 | 41 | 1217 |
GO:0051103 | DNA ligation involved in DNA repair | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0014075 | response to amine | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0001055 | RNA polymerase II activity | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 2 | 6 |
GO:0046134 | pyrimidine nucleoside biosynthetic process | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 6 |
GO:0031000 | response to caffeine | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 6 |
GO:0042555 | MCM complex | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 1 | 6 |
GO:0008380 | RNA splicing | 4.07e-03 | 1.00e+00 | 4.302 | 2 | 7 | 165 |
GO:0000812 | Swr1 complex | 4.29e-03 | 1.00e+00 | 7.861 | 1 | 2 | 7 |
GO:0033151 | V(D)J recombination | 4.29e-03 | 1.00e+00 | 7.861 | 1 | 2 | 7 |
GO:0031011 | Ino80 complex | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 2 | 8 |
GO:0008266 | poly(U) RNA binding | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 9 |
GO:0005736 | DNA-directed RNA polymerase I complex | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 2 | 10 |
GO:0006541 | glutamine metabolic process | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 10 |
GO:0043968 | histone H2A acetylation | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 2 | 10 |
GO:0001054 | RNA polymerase I activity | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 2 | 10 |
GO:0043234 | protein complex | 6.52e-03 | 1.00e+00 | 3.954 | 2 | 8 | 210 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 2 | 11 |
GO:0045120 | pronucleus | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 1 | 11 |
GO:0035267 | NuA4 histone acetyltransferase complex | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 3 | 12 |
GO:0071392 | cellular response to estradiol stimulus | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 1 | 13 |
GO:0005666 | DNA-directed RNA polymerase III complex | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 2 | 13 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 2 | 13 |
GO:0001056 | RNA polymerase III activity | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 2 | 13 |
GO:0035066 | positive regulation of histone acetylation | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 1 | 13 |
GO:0006386 | termination of RNA polymerase III transcription | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 2 | 14 |
GO:0006259 | DNA metabolic process | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 3 | 14 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 2 | 14 |
GO:0005719 | nuclear euchromatin | 9.79e-03 | 1.00e+00 | 6.668 | 1 | 1 | 16 |
GO:0006206 | pyrimidine nucleobase metabolic process | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 2 | 17 |
GO:0006270 | DNA replication initiation | 1.04e-02 | 1.00e+00 | 6.581 | 1 | 4 | 17 |
GO:0071364 | cellular response to epidermal growth factor stimulus | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 18 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 5 | 18 |
GO:0071339 | MLL1 complex | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 2 | 18 |
GO:0033574 | response to testosterone | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 1 | 18 |
GO:0006303 | double-strand break repair via nonhomologous end joining | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 4 | 18 |
GO:0043044 | ATP-dependent chromatin remodeling | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 20 |
GO:0006362 | transcription elongation from RNA polymerase I promoter | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 20 |
GO:0032201 | telomere maintenance via semi-conservative replication | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 7 | 20 |
GO:0071897 | DNA biosynthetic process | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 20 |
GO:0006363 | termination of RNA polymerase I transcription | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 21 |
GO:0017144 | drug metabolic process | 1.28e-02 | 1.00e+00 | 6.276 | 1 | 1 | 21 |
GO:0043967 | histone H4 acetylation | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 2 | 22 |
GO:0000722 | telomere maintenance via recombination | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 7 | 22 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 1.41e-02 | 1.00e+00 | 6.145 | 1 | 1 | 23 |
GO:0000278 | mitotic cell cycle | 1.42e-02 | 1.00e+00 | 3.374 | 2 | 35 | 314 |
GO:0003677 | DNA binding | 1.45e-02 | 1.00e+00 | 2.366 | 3 | 18 | 947 |
GO:0006370 | 7-methylguanosine mRNA capping | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 2 | 24 |
GO:0004003 | ATP-dependent DNA helicase activity | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 25 |
GO:0003730 | mRNA 3'-UTR binding | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 25 |
GO:0031492 | nucleosomal DNA binding | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 25 |
GO:0006360 | transcription from RNA polymerase I promoter | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 2 | 27 |
GO:0034644 | cellular response to UV | 1.71e-02 | 1.00e+00 | 5.861 | 1 | 2 | 28 |
GO:0018107 | peptidyl-threonine phosphorylation | 1.77e-02 | 1.00e+00 | 5.810 | 1 | 2 | 29 |
GO:0006383 | transcription from RNA polymerase III promoter | 1.77e-02 | 1.00e+00 | 5.810 | 1 | 2 | 29 |
GO:0043195 | terminal bouton | 1.89e-02 | 1.00e+00 | 5.714 | 1 | 1 | 31 |
GO:0031490 | chromatin DNA binding | 1.89e-02 | 1.00e+00 | 5.714 | 1 | 1 | 31 |
GO:0007595 | lactation | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 2 | 32 |
GO:0006284 | base-excision repair | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 8 | 32 |
GO:0050434 | positive regulation of viral transcription | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 2 | 35 |
GO:0042542 | response to hydrogen peroxide | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 1 | 36 |
GO:0040008 | regulation of growth | 2.25e-02 | 1.00e+00 | 5.459 | 1 | 2 | 37 |
GO:0035690 | cellular response to drug | 2.31e-02 | 1.00e+00 | 5.421 | 1 | 2 | 38 |
GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 2 | 40 |
GO:0042995 | cell projection | 2.49e-02 | 1.00e+00 | 5.311 | 1 | 2 | 41 |
GO:0003684 | damaged DNA binding | 2.49e-02 | 1.00e+00 | 5.311 | 1 | 9 | 41 |
GO:0000724 | double-strand break repair via homologous recombination | 2.55e-02 | 1.00e+00 | 5.276 | 1 | 5 | 42 |
GO:0031100 | organ regeneration | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 2 | 44 |
GO:0000723 | telomere maintenance | 2.85e-02 | 1.00e+00 | 5.114 | 1 | 8 | 47 |
GO:0032481 | positive regulation of type I interferon production | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 5 | 48 |
GO:0051301 | cell division | 2.97e-02 | 1.00e+00 | 5.054 | 1 | 3 | 49 |
GO:0006310 | DNA recombination | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 6 | 50 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 3.09e-02 | 1.00e+00 | 4.996 | 1 | 5 | 51 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 3 | 52 |
GO:0006302 | double-strand break repair | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 8 | 52 |
GO:0006338 | chromatin remodeling | 3.33e-02 | 1.00e+00 | 4.887 | 1 | 2 | 55 |
GO:0005681 | spliceosomal complex | 3.33e-02 | 1.00e+00 | 4.887 | 1 | 2 | 55 |
GO:0005694 | chromosome | 3.33e-02 | 1.00e+00 | 4.887 | 1 | 1 | 55 |
GO:0071013 | catalytic step 2 spliceosome | 3.69e-02 | 1.00e+00 | 4.738 | 1 | 5 | 61 |
GO:0007565 | female pregnancy | 3.87e-02 | 1.00e+00 | 4.668 | 1 | 2 | 64 |
GO:0010467 | gene expression | 3.88e-02 | 1.00e+00 | 2.605 | 2 | 31 | 535 |
GO:0009653 | anatomical structure morphogenesis | 3.93e-02 | 1.00e+00 | 4.646 | 1 | 1 | 65 |
GO:0051082 | unfolded protein binding | 4.23e-02 | 1.00e+00 | 4.539 | 1 | 4 | 70 |
GO:0006325 | chromatin organization | 4.23e-02 | 1.00e+00 | 4.539 | 1 | 3 | 70 |
GO:0001889 | liver development | 4.29e-02 | 1.00e+00 | 4.519 | 1 | 1 | 71 |
GO:0001649 | osteoblast differentiation | 4.46e-02 | 1.00e+00 | 4.459 | 1 | 2 | 74 |
GO:0030529 | ribonucleoprotein complex | 4.94e-02 | 1.00e+00 | 4.311 | 1 | 4 | 82 |
GO:0006260 | DNA replication | 5.64e-02 | 1.00e+00 | 4.114 | 1 | 11 | 94 |
GO:0006457 | protein folding | 5.82e-02 | 1.00e+00 | 4.069 | 1 | 4 | 97 |
GO:0016887 | ATPase activity | 5.99e-02 | 1.00e+00 | 4.025 | 1 | 6 | 100 |
GO:0007507 | heart development | 6.34e-02 | 1.00e+00 | 3.941 | 1 | 1 | 106 |
GO:0046777 | protein autophosphorylation | 6.34e-02 | 1.00e+00 | 3.941 | 1 | 2 | 106 |
GO:0070062 | extracellular vesicular exosome | 6.36e-02 | 1.00e+00 | 1.573 | 3 | 43 | 1641 |
GO:0000790 | nuclear chromatin | 6.51e-02 | 1.00e+00 | 3.900 | 1 | 3 | 109 |
GO:0004672 | protein kinase activity | 7.44e-02 | 1.00e+00 | 3.703 | 1 | 2 | 125 |
GO:0000082 | G1/S transition of mitotic cell cycle | 7.44e-02 | 1.00e+00 | 3.703 | 1 | 24 | 125 |
GO:0005829 | cytosol | 7.91e-02 | 1.00e+00 | 1.450 | 3 | 58 | 1787 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 8.42e-02 | 1.00e+00 | 3.519 | 1 | 2 | 142 |
GO:0005622 | intracellular | 8.59e-02 | 1.00e+00 | 3.489 | 1 | 1 | 145 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 9.50e-02 | 1.00e+00 | 3.338 | 1 | 4 | 161 |
GO:0043025 | neuronal cell body | 1.01e-01 | 1.00e+00 | 3.251 | 1 | 3 | 171 |
GO:0000166 | nucleotide binding | 1.03e-01 | 1.00e+00 | 3.209 | 1 | 6 | 176 |
GO:0019899 | enzyme binding | 1.22e-01 | 1.00e+00 | 2.954 | 1 | 4 | 210 |
GO:0043231 | intracellular membrane-bounded organelle | 1.27e-01 | 1.00e+00 | 2.900 | 1 | 7 | 218 |
GO:0006200 | ATP catabolic process | 1.27e-01 | 1.00e+00 | 2.894 | 1 | 8 | 219 |
GO:0003723 | RNA binding | 1.43e-01 | 1.00e+00 | 2.720 | 1 | 11 | 247 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.92e-01 | 1.00e+00 | 2.255 | 1 | 6 | 341 |
GO:0005794 | Golgi apparatus | 2.29e-01 | 1.00e+00 | 1.971 | 1 | 5 | 415 |
GO:0016032 | viral process | 2.36e-01 | 1.00e+00 | 1.927 | 1 | 32 | 428 |
GO:0045087 | innate immune response | 2.48e-01 | 1.00e+00 | 1.848 | 1 | 7 | 452 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 3.36e-01 | 1.00e+00 | 1.338 | 1 | 8 | 644 |
GO:0005739 | mitochondrion | 3.43e-01 | 1.00e+00 | 1.304 | 1 | 11 | 659 |
GO:0008270 | zinc ion binding | 3.71e-01 | 1.00e+00 | 1.163 | 1 | 7 | 727 |
GO:0044822 | poly(A) RNA binding | 4.01e-01 | 1.00e+00 | 1.026 | 1 | 25 | 799 |
GO:0044281 | small molecule metabolic process | 4.19e-01 | 1.00e+00 | 0.947 | 1 | 32 | 844 |
GO:0046872 | metal ion binding | 4.53e-01 | 1.00e+00 | 0.801 | 1 | 10 | 934 |
GO:0005515 | protein binding | 5.02e-01 | 1.00e+00 | 0.244 | 3 | 76 | 4124 |
GO:0006351 | transcription, DNA-templated | 5.04e-01 | 1.00e+00 | 0.597 | 1 | 9 | 1076 |
GO:0005737 | cytoplasm | 8.48e-01 | 1.00e+00 | -0.694 | 1 | 50 | 2633 |